CN101724069B - Preparation method of yolk antibody IgY of high-abundance protein in anti-human serum/blood plasma and application thereof - Google Patents

Preparation method of yolk antibody IgY of high-abundance protein in anti-human serum/blood plasma and application thereof Download PDF

Info

Publication number
CN101724069B
CN101724069B CN 200910254437 CN200910254437A CN101724069B CN 101724069 B CN101724069 B CN 101724069B CN 200910254437 CN200910254437 CN 200910254437 CN 200910254437 A CN200910254437 A CN 200910254437A CN 101724069 B CN101724069 B CN 101724069B
Authority
CN
China
Prior art keywords
antibody
yolk
egg
abundance proteins
igy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN 200910254437
Other languages
Chinese (zh)
Other versions
CN101724069A (en
Inventor
崔亚丽
胡佳
陈超
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shaanxi Lifegen Co Ltd
Xi'an Goldmag Nanobiotech Co Ltd
Original Assignee
SHAANXI BEIMEI GENE CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHAANXI BEIMEI GENE CO Ltd filed Critical SHAANXI BEIMEI GENE CO Ltd
Priority to CN 200910254437 priority Critical patent/CN101724069B/en
Publication of CN101724069A publication Critical patent/CN101724069A/en
Application granted granted Critical
Publication of CN101724069B publication Critical patent/CN101724069B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

The invention relates to a preparation method of a yolk antibody IgY of high-abundance protein in anti-human serum/blood plasma and application thereof; and eggs of a hen immunized by high-abundance protein are used as a source for extracting antibody. The preparation method comprises the steps of: detecting the serum potency of the immunized hen through an indirect ELISA method, obtaining an egg containing antibody with high potency after the potency meets the standard; acid hydrolyzing, freeze thawing and filtering the egg yolk liquid, and depositing by using ammonium sulphate; and further purifying through DEAE ion exchange layer chromatograph to obtain the yolk antibody IgY. The high-abundance protein of human serum/blood plasma is a high-abundance protein with albumin, IgG, transferrin, C3 alexin, IgA, IgM, trypsin, globin, lipoprotein, F factor, C9 alexin, C4 alexin, ceruloplasmin, apolipoprotein B, apolipoprotein A-1, alpha-1-acid glycoprotein, H factor, alexin factor B, prealbumin and C1q alexin, and the like, and the concentration of which are higher than 10 mug/ml.

Description

Preparation method and the application thereof of high-abundance proteins yolk antibody IgY in a kind of AHS/slurry
Technical field
The present invention relates to preparation method and the application thereof of high-abundance proteins yolk antibody IgY in a kind of AHS/slurry.
Background technology
Contain organism tissue emiocytosis in serum human/biological samples such as slurry, drop to the multiple low abundance proteins in the blood, they may be the key proteins of some signal conduction and regulation and control.For example, in necrosis, apoptosis or the haemolysis process, all can there be some intracellular protein to be discharged in the blood.Carry out the serum photeomics research of disease, seek low abundance proteins, will be conducive to illustrate pathogeny, and might find the significant protein that some are relevant with the disease particular state, thereby provide novel method for the diagnosis of disease.Yet the existence of some high-abundance proteins matter, especially albumin and antibody have had a strong impact on the Identification and detection of low abundance proteins.
Often utilize the high-abundance proteins matter in the antibody affinity chromatography method removal sample in the proteomics research, to improve sensitivity and the resolving power that low-abundance protein is detected.The key of utilizing antibody affinity chromatography removal technology is to obtain the high and antibody cheap and easy to get of specificity, and the antibody affinity chromatography fado adopts recombinant monoclonal or the polyclonal antibody in Mammals source now.The normal operation rabbit, the Mammalss such as mouse are as the animal-origin that produces high-abundance proteins antibody in antiserum(antisera)/blood plasma.Mammiferous monoclonal antibody preparation is complicated, and output is little, and cost is high; There are the problems referred to above equally in its polyclonal antibody that derives from blood plasma, and can have the shortcoming of non-specific binding.
Summary of the invention
The object of the present invention is to provide preparation method and the application thereof of high-abundance proteins antibody in a kind of AHS/slurry, it has solved and has used rabbit in the prior art, the Mammalss such as mouse are as the animal-origin that produces high-abundance proteins antibody in antiserum(antisera)/blood plasma, use mammalian blood serum as extracting antibody sources, cause the preparation process of antibody complicated, output is little, and cost is high, the problems such as antibody has non-specific binding, and it is low and unstable to tire; And solved Mammals source antibody in albumen sepn, the non-specific separation problem that causes in the extraction.Mammals source antibody non-specific adsorption and assorted effect of signals problem of causing in immunology detection have been solved.
The thinking that the present invention addresses the above problem is: bird kind is being that generation has the sibship farther with Mammals, can have the more antibody of high specific for a large amount of conservative protein antigens generations in the Evolution of Mammals, and it is little to produce the required antigen amount of effective immune response.The egg of use hen after immunity replaces animal serum, as the source of extracting antibody.In recent years, Yolk immunoglobulin (immunoglobulin of yolk, be called for short IgY), because of output is large, high specificity, obtain conveniently, low cost and other advantages, more and more be applied to diagnosis, prevention and the treatment of disease, become a kind of reliable and stable antibody sources.The specific IgY of anti-human blood plasma high-abundance proteins can be covalently bonded in solid support, removes the high-abundance proteins in the blood plasma, such as albumin, Transferrins,iron complexes, Fibrinogen, immunoglobulin (Ig) (IgA, IgM, IgG) etc.
The technical scheme that the present invention addresses the above problem is: the preparation method of high-abundance proteins antibody IgY may further comprise the steps in a kind of AHS who provides/slurry:
1, collects the egg that contains high-titer antibody that produces through hen after the high-abundance proteins immunity.The described egg that contains high-titer antibody is to determine like this: detect through the tiring of high-abundance proteins immunity stepmother chicken serum with indirect elisa method, tiring is the high-titer antibody egg after up to standard;
2, separation and Extraction high-abundance proteins yolk antibody IgY from the high-titer antibody egg: the yolk liquid of described high-titer antibody egg is dissolved through sour water, freeze thawing, filter, ammonium sulfate precipitation and DEAE anion-exchange chromatography are the separable high-abundance proteins yolk antibody IgY that obtains purifying.
The separation and Extraction of step 2 high-abundance proteins yolk antibody the steps include:
(1) albumen and the vitelline membrane of removal high-titer egg obtain yolk liquid, with ultrapure water dilution yolk liquid, press ultrapure water and yolk liquid 1: 2-1: 15 volume ratio, adjust the pH of diluent in the 4.5-6.0 scope, and 4 ℃ are stirred 9h to spending the night.After yolk diluent is frozen, place 4 ℃ of slowly dissolvings, filter.Filtrate is collected supernatant through the centrifugal 20min of 11000rpm.
(2) above-mentioned supernatant liquor saturated ammonium sulphate 2 times, ultimate density is respectively 50% and 35%.The centrifugal 25min of 11000rpm abandons supernatant, and precipitation is dissolved with PBS.4 ℃ of dialysis 24h, liquid is changed 4 times in the centre.The yolk antibody crude product of dialysing to get.
(3) under 6.8~7.0 nearly neutral environment, yolk antibody is carried out purifying with the DEAE anion-exchange column, 1mol/L NaCl gradient elution, flow velocity 1mL/min.Collect elutriant, be yolk antibody solution.
The step 1 pair serum through hen after the immunity carries out bioactivity, obtains the egg that contains high-titer antibody, the steps include:
(1.1) detect immune serum with indirect elisa method and tire, detect the absorbance value of 450nm with microplate reader, tire take the absorbance value of the positive serum 450nm minimum extent of dilution of serum during greater than 2.1 times of negative control mean values as ELISA.
(1.2) detect immune serum with indirect elisa method and tire, ELISA collects egg after tiring and reaching 1: 10000,4 ℃ of preservations.
High-abundance proteins described in the present invention is albumin, IgG, Transferrins,iron complexes, C3 complement, IgA, IgM, Trypsin, globin, lipoprotein, F-factor, C9 complement, the C4 complement, copper-protein, apolipoprotein B, aPoA-I, α-1-acid glycoprotein, the H factor, complement factor B, prealbumin, C1q complement isoconcentration is higher than the high-abundance proteins of 10 μ g/ml.
Among the present invention in AHS/slurry the high-abundance proteins yolk antibody IgY use and to comprise: the immune affinity extraction of high-abundance proteins, the immune affine separation of high-abundance proteins, the immunology detection of high-abundance proteins.
Advantage of the present invention is:
When 1, preparing the high-abundance proteins yolk antibody IgY, it is convenient to collect egg, need not blood sampling, and not damaged meets modern protection of animal rule.
2, antibody production is high, and the time that maintains high-titer is long, and is with low cost.Egg-laying bird can produce more efficient valency and the length of holding time soon in egg after immunity.Yolk antibody output is large, and each egg approximately contains the above IgY of 100mg, can reach 3g in one month, is equivalent to the 10-12 of rabbit doubly.Because the breeding expenses of bird is with cheap, and can produce high-titer antibody for a long time, its cost is well below extract corresponding antibodies from mammalian plasma.
3, antibody separation and Extraction convenience and purity are high.The Ig that does not have other in the yolk is easy to purify.The IgY crude product purity of utilizing ammonium sulfate precipitation method to be separated to just reaches more than 90%.
4, IgY is more stable, is easy to store.Because be subject to the protection of yolk, egg is stored in lower 6 months of 4 ℃ of conditions, the IgY activity only has very small loss.And IgY is more acidproof than Mammals antibody, and is alkaline-resisting, heat-resisting.
5, yolk antibody the height of tiring that the proteantigen in Mammals source is produced, high specificity, and it is little to produce the required antigen amount of effective immune response.
6, the yolk antibody of anti-high-abundance proteins is applied to the immune affinity extraction of high-abundance proteins, the immune affine separation of high-abundance proteins, the immunology detection of high-abundance proteins.The immune affinity extraction of high-abundance proteins, the immune affine separation of high-abundance proteins have been solved, the non-specific problem in the immunology detection of high-abundance proteins.
Description of drawings
Fig. 1 is yolk antibody IgY separation and Extraction SDS-PAGE electrophorogram, the high-abundance proteins IgY that swimming lane 1 obtains for purifying, and swimming lane 2 is high-abundance proteins IgY mark product.
Embodiment
Embodiment 1 is the IgY preparation process of anti-Transferrins,iron complexes chicken:
1, the egg through hen after the Transferrins,iron complexes immunity is detected, obtain the egg that contains high-titer antibody.Concrete steps are:
(1) detects immune serum with indirect elisa method and tire, detect the absorbance value of 450nm with microplate reader, tire take the absorbance value of the positive serum 450nm minimum extent of dilution of serum during greater than 2.1 times of negative control mean values as ELISA.
(2) detect immune serum with indirect elisa method and tire, ELISA collects egg after tiring and reaching 1: 10000,4 ℃ of preservations.
2, separation and Extraction high-abundance proteins yolk antibody IgY from the high-titer antibody egg: the yolk liquid of described high-titer antibody egg is dissolved through sour water, freeze thawing, filter, ammonium sulfate precipitation and DEAE-fast-flow ion exchange chromatography are the separable high-abundance proteins yolk antibody IgY that obtains purifying.Concrete steps are:
(1) albumen and the vitelline membrane of removal high-titer egg obtain yolk liquid, with ultrapure water and 1: 9 volume ratio of yolk liquid dilution yolk liquid, diluent are adjusted to about PH=5.5, and 4 ℃ are stirred 9h to spending the night.After yolk diluent is frozen, place 4 ℃ of slowly dissolvings, filter.Filtrate is collected supernatant through the centrifugal 20min of 11000rpm.
(2) above-mentioned supernatant liquor saturated ammonium sulphate 2 times, ultimate density is respectively 50% and 35%.The centrifugal 25min of 11000rpm abandons supernatant, and precipitation is dissolved with PBS.4 ℃ of dialysis 24h, liquid is changed 4 times in the centre.The yolk antibody crude product of dialysing to get.
(3) under 6.8~7.0 nearly neutral environment, yolk antibody is carried out purifying with the DEAE anion-exchange column, 1mol/L NaCl gradient elution, flow velocity 1mL/min.Collect elutriant, be yolk antibody solution.
(4) as can be seen from Figure 1, in swimming lane 1 and the swimming lane 2, same strap occurs in same position, illustrate to extract to have obtained yolk antibody IgY.
Embodiment 2 is the IgY preparation process of antialbumin chicken:
1, the serum through hen after the albumin immunity is carried out bioactivity, obtain the egg that contains high-titer antibody.Concrete steps are:
(1) detects immune serum with indirect elisa method and tire, detect the absorbance value of 450nm with microplate reader, tire take the absorbance value of the positive serum 450nm minimum extent of dilution of serum during greater than 2.1 times of negative control mean values as ELISA.
(2) detect immune serum with indirect elisa method and tire, ELISA collects egg after tiring and reaching 1: 10000,4 ℃ of preservations.
2, separation and Extraction high-abundance proteins yolk antibody IgY from the high-titer antibody egg: the yolk liquid of described high-titer antibody egg is dissolved through sour water, freeze thawing, filter, ammonium sulfate precipitation and DEAE ion exchange chromatography are the separable high-abundance proteins yolk antibody IgY that obtains purifying.
(1) albumen and the vitelline membrane of removal high-titer egg obtain yolk liquid, with ultrapure water and 1: 9 volume ratio of yolk liquid dilution yolk liquid, diluent are adjusted to about PH=5.5, and 4 ℃ are stirred 9h to spending the night.After yolk diluent is frozen, place 4 ℃ of slowly dissolvings, filter.Filtrate is collected supernatant through the centrifugal 20min of 11000rpm.
(2) above-mentioned supernatant liquor saturated ammonium sulphate 2 times, ultimate density is respectively 50% and 35%.The centrifugal 25min of 11000rpm abandons supernatant, and precipitation is dissolved with PBS.4 ℃ of dialysis 24h, liquid is changed 4 times in the centre.The yolk antibody crude product of dialysing to get.
(3) under 6.8~7.0 nearly neutral environment, yolk antibody is carried out purifying with the DEAE anion-exchange column, 1mol/L NaCl gradient elution, flow velocity 1mL/min.Collect elutriant, be yolk antibody solution.
(4) as can be seen from Figure 1, in swimming lane 1 and the swimming lane 2, same strap occurs in same position, illustrate to extract to have obtained highly purified yolk antibody IgY.

Claims (3)

1. the preparation method of high-abundance proteins yolk antibody IgY in AHS/slurry, it is characterized in that: described preparation process may further comprise the steps
(1) collects the egg that contains high-titer antibody that produces through hen after the high-abundance proteins immunity; The described egg that contains high-titer antibody is to determine like this: detect through the tiring of high-abundance proteins immunity stepmother chicken serum with indirect elisa method, tiring is the high-titer antibody egg after up to standard;
(2) imitate the anti-high-abundance proteins yolk antibody IgY of separation and Extraction the antibody egg from high price: the yolk liquid of described high-titer antibody egg is diluted through sour water, through freeze thawing, filtration obtains containing the aqueous solution of yolk antibody IgY, ammonium sulfate precipitation is slightly pure, and the DEAE ion exchange chromatography is the separable high-abundance proteins yolk antibody IgY that obtains purifying;
Step (2) specifically operates according to following steps:
(2.1) albumen and the vitelline membrane of removing the high-titer egg obtain yolk liquid, with ultrapure water dilution yolk liquid, the volume ratio of pressing yolk liquid and ultrapure water 1:2-1:15, and diluent are adjusted pH in the 4.5-6.0 scope, and 4 ℃ of stirring 9h are to spending the night; After yolk diluent is frozen, place 4 ℃ of slowly dissolvings, filter; Filtrate is collected supernatant and is the aqueous solution that contains yolk antibody IgY through the centrifugal 20min of 11000rpm;
(2.2) aqueous solution supernatant that contains yolk antibody IgY is with saturated ammonium sulphate 2 times, and final concentration is respectively 50% and 35%; The centrifugal 25min of 11000rpm abandons supernatant, and precipitation is dissolved with PBS; 4 ℃ of dialysis 24 h, liquid is changed 4 times in the centre; Dialysis obtains the yolk antibody crude product;
(2.3) under the nearly neutral environment of pH 6.8~7.0, yolk antibody is carried out purifying with the DEAE anion-exchange column, 1 mol/L NaCl gradient elution, flow velocity 1mL/min; Collect elutriant, obtain yolk antibody solution.
2. the preparation method of high-abundance proteins yolk antibody IgY in AHS according to claim 1/slurry, it is characterized in that: step (1) detects tiring through high-abundance proteins immunity stepmother chicken serum, obtain the egg that contains high-titer antibody, the steps include:
(1.1) detect immune serum with indirect elisa method and tire, detect the absorbance value of 450nm with microplate reader, tire take the absorbance value of the positive serum 450nm minimum extent of dilution of serum during greater than 2.1 times of negative control mean values as ELISA;
(1.2) detect immune serum with indirect elisa method and tire, ELISA collects egg after tiring and reaching 1:10 000,4 ℃ of preservations.
3. the preparation method of high-abundance proteins yolk antibody IgY in AHS according to claim 1 and 2/slurry, it is characterized in that: described high-abundance proteins is albumin, IgG, Transferrins,iron complexes, the C3 complement, IgA, IgM, Trypsin, globin, lipoprotein, F-factor, C9 complement, the C4 complement, copper-protein, apolipoprotein B, aPoA-I, α-1-acid glycoprotein, the H factor, complement factor B, prealbumin, the C1q complement, the concentration of described high-abundance proteins is higher than 10 μ g/ml.
CN 200910254437 2009-12-22 2009-12-22 Preparation method of yolk antibody IgY of high-abundance protein in anti-human serum/blood plasma and application thereof Active CN101724069B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200910254437 CN101724069B (en) 2009-12-22 2009-12-22 Preparation method of yolk antibody IgY of high-abundance protein in anti-human serum/blood plasma and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200910254437 CN101724069B (en) 2009-12-22 2009-12-22 Preparation method of yolk antibody IgY of high-abundance protein in anti-human serum/blood plasma and application thereof

Publications (2)

Publication Number Publication Date
CN101724069A CN101724069A (en) 2010-06-09
CN101724069B true CN101724069B (en) 2013-03-06

Family

ID=42445682

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200910254437 Active CN101724069B (en) 2009-12-22 2009-12-22 Preparation method of yolk antibody IgY of high-abundance protein in anti-human serum/blood plasma and application thereof

Country Status (1)

Country Link
CN (1) CN101724069B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113264998B (en) * 2021-01-28 2023-02-28 四川大学华西医院 Single-chain antibody of S1 protein on surface of anti-new coronavirus SARS-CoV-2 and application thereof
CN113150129B (en) * 2021-01-28 2023-02-28 四川大学华西医院 Single-chain antibody for resisting S2 protein on surface of new coronavirus SARS-CoV-2 and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1724569A (en) * 2005-06-30 2006-01-25 上海交通大学 Preparation method of vitelline antibody for resisting pstudorabies
CN1268643C (en) * 2003-11-25 2006-08-09 中国人民解放军军事医学科学院微生物流行病研究所 Antibody against SARS-CoV IgY and its preparing method
CN101343320A (en) * 2008-07-01 2009-01-14 华南农业大学 Anti-vibrio parahaemolyticus chicken yolk antibody, preparation method and application thereof
CN101564534A (en) * 2008-11-12 2009-10-28 大连理工大学 Specific yolk antibody preparation for controlling halitosis pathogens and application thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1268643C (en) * 2003-11-25 2006-08-09 中国人民解放军军事医学科学院微生物流行病研究所 Antibody against SARS-CoV IgY and its preparing method
CN1724569A (en) * 2005-06-30 2006-01-25 上海交通大学 Preparation method of vitelline antibody for resisting pstudorabies
CN101343320A (en) * 2008-07-01 2009-01-14 华南农业大学 Anti-vibrio parahaemolyticus chicken yolk antibody, preparation method and application thereof
CN101564534A (en) * 2008-11-12 2009-10-28 大连理工大学 Specific yolk antibody preparation for controlling halitosis pathogens and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
林芳 等.鸡卵黄抗体的制备以及金磁微粒为载体去除人血浆部分高丰度蛋白的研究.《细胞与分子免疫学杂志》.2008,706-709. *

Also Published As

Publication number Publication date
CN101724069A (en) 2010-06-09

Similar Documents

Publication Publication Date Title
CN102220286B (en) Hybridoma cell strain 2C9, anti-aflatoxin M1 monoclonal antibody produced by hybridoma cell strain 2C9 and application thereof
Nishi et al. Purification of human, dog and rabbit α-fetoprotein by immunoadsorbents of Sepharose coupled with anti-human α-fetoprotein
De Meulenaer et al. Isolation and purification of chicken egg yolk immunoglobulins: a review
Ko et al. Preparation of immunoglobulin Y from egg yolk using ammonium sulfate precipitation and ion exchange chromatography
TWI226834B (en) Process for selectively isolating antibody isomers
Kim et al. Simple separation of immunoglobulin from egg yolk by ultrafiltration
CN101724069B (en) Preparation method of yolk antibody IgY of high-abundance protein in anti-human serum/blood plasma and application thereof
CN103215231A (en) Hybridoma cell strain 1H2, anti-ochratoxin A monoclonal antibody produced from same and application thereof
CN101830983A (en) Preparation and application of specific sequence-based aquaporin 4 high titer antibody
CN101125886B (en) Method for extracting yolk immunoglobulin
CN108287235A (en) A kind of efficient, stable magnetic immuno-microsphere preparation and application
Gee et al. The purification of IgY from chicken egg yolk by preparative electrophoresis
US4368148A (en) Protein PP9, process for its enrichment and its isolation and its use
CN108148127A (en) A kind of people MAP3K7IP2 polypeptides and its preparation method for antibody
CN102539778A (en) Enzyme linked immunosorbent assay kit for detecting recombinant human tumor necrosis factor-alpha
CN204882575U (en) A pick -up plate that is used for heparin binding protein fluorescence immunity chromatography method quantitative determination kit
CN101045750B (en) Extraction process of camel colostrum immune globulin IgA, IgG.
CN1935841A (en) Anti hepatitis B virus chicken yolk immune globulin IgY and its separating method
Nafea et al. Development of hen antihepatitis B antigen IgY-based conjugate for ELISA assay
CN111793122B (en) Method for opening V-domain of natural beta 2 glycoprotein I, antigen prepared by using method, application and kit
CN103071315B (en) Preparation and application of minitype efficient salbutamol immunoaffinity purification enriching column
Morgan et al. Extraction and purification of IgY
CN104072586B (en) The detection reagent and kit of people's kidney injury molecule-1
CN102565410A (en) Immunologic detection method for sika deer prion protein
CN101928332A (en) Preparation method of Human HNRPA0 polypeptide and antibody thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: XI AN GOLDMAG NANOBIOTECH CO., LTD.

Free format text: FORMER OWNER: SHAANXI BAIMEI GENE CO., LTD.

Effective date: 20130718

C41 Transfer of patent application or patent right or utility model
C56 Change in the name or address of the patentee

Owner name: SHAANXI BAIMEI GENE CO., LTD.

Free format text: FORMER NAME: SHAANXI LIFEGEN CO., LTD.

COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 710069 XI AN, SHAANXI PROVINCE TO: 710077 XI AN, SHAANXI PROVINCE

CP01 Change in the name or title of a patent holder

Address after: 710069 Shaanxi city of Xi'an province Taibai Road No. 229

Patentee after: SHAANXI LIFEGEN Co.,Ltd.

Address before: 710069 Shaanxi city of Xi'an province Taibai Road No. 229

Patentee before: Shaanxi North American Gene Co.,Ltd.

TR01 Transfer of patent right

Effective date of registration: 20130718

Address after: 710077, Shaanxi, Xi'an hi tech Zone, No. 85, No. 4, No. 2, modern enterprise center, 3 east side, 10402A

Patentee after: XI'AN GOLDMAG NANOBIOTECH Co.,Ltd.

Address before: 710069 Shaanxi city of Xi'an province Taibai Road No. 229

Patentee before: SHAANXI LIFEGEN Co.,Ltd.